Ketorolac vs. Depomedrol Injections for Subacromial Impingement
Outcomes of ketorolac versus depomedrol infiltrations for subacromial impingement syndrome: a randomized controlled trialMusculoskelet Surg . 2022 Mar;106(1):29-34.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Seventy patients with subacromial impingement syndrome were randomized to receive a subacromial depomedrol injection (n=35) or a subacromial ketorolac injection (n=35). The outcomes of interest included pain, function and range of motion at one and three month follow-up. There was no significant differences in pain as measured by a visual analogue scale. No differences in function between the two ...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue